Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEOP Alternating With Pralatrexate for PTCL
NCT01336933Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Jul 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pralatrexate in peripheral T-cell lymphoma (PTCL), sponsored by University of Nebraska. Started Jul 2011; status: completed.
02
Drugs
pralatrexate
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01336933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336933.